{{Rsnum
|rsid=934635
|Chromosome=15
|position=51186580
|Orientation=plus
|GMAF=0.1175
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 28.6 | 69.6
| HCB | 0.0 | 4.4 | 95.6
| JPT | 0.0 | 2.7 | 97.3
| YRI | 0.7 | 15.6 | 83.7
| ASW | 1.8 | 10.5 | 87.7
| CHB | 0.0 | 4.4 | 95.6
| CHD | 0.0 | 5.5 | 94.5
| GIH | 1.0 | 29.7 | 69.3
| LWK | 0.0 | 15.5 | 84.5
| MEX | 3.4 | 39.7 | 56.9
| MKK | 3.2 | 23.1 | 73.7
| TSI | 2.0 | 26.5 | 71.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=24590773
|Title=Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
}}

{{on chip | Affy GenomeWide 6}}